Bone Biologics (BBLG) Enterprise Value (2012 - 2025)
Bone Biologics (BBLG) reported Enterprise Value of -$5.3 million for Q4 2025, down 60.42% year-over-year from -$13.5 million in Q4 2024, and up 11.82% quarter-over-quarter from -$6.0 million in Q3 2025.
Bone Biologics (BBLG) Enterprise Value (2012 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 14 years of Enterprise Value data on file, last reported at -$5.3 million in Q4 2025.
- Enterprise Value for Q4 2025 came in at -$5.3 million, down 60.42% year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.3 million (down 60.42% YoY), and the FY2025 annual result was -$5.3 million, down 60.42% from the prior year.
- Enterprise Value advanced to -$5.3 million in Q4 2025 per BBLG's latest filing, from -$6.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$3374.0 in Q3 2021 and troughed at -$7.5 million in Q4 2022.
- A 5-year average of -$4.2 million and a median of -$4.8 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value plunged 149847.93% in 2022, then surged 66.72% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$6.7 million in 2021, then dropped by 12.93% to -$7.5 million in 2022, then soared by 59.85% to -$3.0 million in 2023, then fell by 9.86% to -$3.3 million in 2024, then sank by 60.42% to -$5.3 million in 2025.
- Business Quant data shows BBLG's Enterprise Value at -$5.3 million in Q4 2025, -$6.0 million in Q3 2025, and -$6.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -584.73 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | -5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.33 Mn |
| Sep 30, 2025 | -6.05 Mn |
| Jun 30, 2025 | -6.64 Mn |
| Mar 31, 2025 | -2.75 Mn |
| Dec 31, 2024 | -3.33 Mn |
| Sep 30, 2024 | -3.57 Mn |
| Jun 30, 2024 | -2.33 Mn |
| Mar 31, 2024 | -3.23 Mn |
| Dec 31, 2023 | -3.03 Mn |
| Sep 30, 2023 | -4.45 Mn |
| Jun 30, 2023 | -7.01 Mn |
| Mar 31, 2023 | -6.19 Mn |
| Dec 31, 2022 | -7.54 Mn |
| Sep 30, 2022 | -5.06 Mn |
| Jun 30, 2022 | -5.45 Mn |
| Mar 31, 2022 | -5.81 Mn |
| Dec 31, 2021 | -6.68 Mn |
| Sep 30, 2021 | -3,374.00 |
| Jun 30, 2021 | -4,438.00 |
| Mar 31, 2021 | -71,165.00 |